BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 17108015)

  • 1. Ocular complications in newly diagnosed borderline lepromatous and lepromatous leprosy patients: baseline profile of the Indian cohort.
    Daniel E; Koshy S; Rao GS; Rao PS
    Br J Ophthalmol; 2002 Dec; 86(12):1336-40. PubMed ID: 12446359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twelve months fixed duration WHO multidrug therapy for multibacillary leprosy: incidence of relapses in Agra field based cohort study.
    Kumar A; Girdhar A; Girdhar BK
    Indian J Med Res; 2013 Oct; 138(4):536-40. PubMed ID: 24434261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactions following completion of 1 and 2 year multidrug therapy (MDT).
    Balagon MV; Gelber RH; Abalos RM; Cellona RV
    Am J Trop Med Hyg; 2010 Sep; 83(3):637-44. PubMed ID: 20810832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of vision reducing cataract in skin smear positive lepromatous patients: does it have an inflammatory basis?
    Daniel E; Sundar Rao PS
    Br J Ophthalmol; 2007 Aug; 91(8):1011-3. PubMed ID: 17301116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasonography of Leprosy Neuropathy: A Longitudinal Prospective Study.
    Lugão HB; Frade MA; Marques W; Foss NT; Nogueira-Barbosa MH
    PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005111. PubMed ID: 27851766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a conditional cash transfer programme on leprosy treatment adherence and cure in patients from the nationwide 100 Million Brazilian Cohort: a quasi-experimental study.
    Pescarini JM; Williamson E; Nery JS; Ramond A; Ichihara MY; Fiaccone RL; Penna MLF; Smeeth L; Rodrigues LC; Penna GO; Brickley EB; Barreto ML
    Lancet Infect Dis; 2020 May; 20(5):618-627. PubMed ID: 32066527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered composition and functional profile of high-density lipoprotein in leprosy patients.
    Lemes RMR; Silva CAME; Marques MÂM; Atella GC; Nery JADC; Nogueira MRS; Rosa PS; Soares CT; De P; Chatterjee D; Pessolani MCV; de Macedo CS
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008138. PubMed ID: 32226013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral nerve abnormality in HIV leprosy patients.
    Xavier MB; do Nascimento MGB; Batista KNM; Somensi DN; Juca Neto FOM; Carneiro TX; Gomes CMC; Corbett CEP
    PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006633. PubMed ID: 30020931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial activation is associated with albuminuria in multibacillary leprosy.
    Tessarolo LD; Meneses GC; Bezerra GF; Rocha TPD; Azevedo IEP; Silva Junior GB; Pontes MAA; Daher EF; Martins AMC
    Rev Inst Med Trop Sao Paulo; 2021; 63():e44. PubMed ID: 34161550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Six months fixed duration multidrug therapy in paucibacillary leprosy: risk of relapse and disability in Agra PB cohort study.
    Kumar A; Girdhar A; Girdhar BK
    BMJ Open; 2012; 2(4):. PubMed ID: 22893667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moth-Eaten Appearance of the Iris in Hansen Disease.
    Mahendradas P; Rajendran J; Sriram R
    JAMA Ophthalmol; 2023 Nov; 141(11):e232470. PubMed ID: 37971507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iris atrophy in patients with newly diagnosed multibacillary leprosy: at diagnosis, during and after completion of multidrug treatment.
    Daniel E; Sundar Rao PS; Ffytche TJ; Chacko S; Prasanth HR; Courtright P
    Br J Ophthalmol; 2007 Aug; 91(8):1019-22. PubMed ID: 17108015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular hypotension and hypotony in multibacillary leprosy patients; at diagnosis, during and after completion of multidrug therapy.
    Daniel E; Rao PS; Ffytche TJ; Courtright P
    Indian J Lepr; 2010; 82(4):181-8. PubMed ID: 21434594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of ocular morbidity among multibacillary leprosy patients during a 2 year course of multidrug therapy.
    Daniel E; Ffytche TJ; Sundar Rao PS; Kempen JH; Diener-West M; Courtright P
    Br J Ophthalmol; 2006 May; 90(5):568-73. PubMed ID: 16622085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of ocular complications in patients with multibacillary leprosy after completion of a 2 year course of multidrug therapy.
    Daniel E; Ffytche TJ; Kempen JH; Rao PS; Diener-West M; Courtright P
    Br J Ophthalmol; 2006 Aug; 90(8):949-54. PubMed ID: 16707521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relapses among leprosy patients treated with multidrug therapy: experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia; practical difficulties with diagnosing relapses; operational procedures and criteria for diagnosing relapses.
    Becx-Bleumink M
    Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):421-35. PubMed ID: 1474281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practical problems in the management of leprosy.
    Ramesh V; Porichha D
    Lepr Rev; 1996 Dec; 67(4):330-6. PubMed ID: 9033204
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.